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Dietary supplement use and smoking are important correlates of 
biomarkers of water-soluble vitamin status after adjusting for 
sociodemographic and lifestyle variables in a representative 
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Abstract
Biochemical indicators of water-soluble vitamin (WSV) status have been measured in a nationally 
representative sample of the US population in NHANES 2003–2006. To examine whether 
demographic differentials in nutritional status were related to and confounded by certain variables, 
we assessed the association of sociodemographic (age, sex, race-ethnicity, education, income) and 
lifestyle variables (dietary supplement use, smoking, alcohol consumption, BMI, physical activity) 
with biomarkers of WSV status in adults (≥20 y): serum and RBC folate, serum pyridoxal-5′-
phosphate (PLP), serum 4-pyridoxic acid, serum total cobalamin (B-12), plasma total 
homocysteine (tHcy), plasma methylmalonic acid (MMA), and serum ascorbic acid. Age (except 
for PLP) and smoking (except for MMA) were generally the strongest significant correlates of 
these biomarkers (|r| ≤0.43) and together with supplement use explained more of the variability as 
compared to the other covariates in bivariate analysis. In multiple regression models, 
sociodemographic and lifestyle variables together explained from 7% (B-12) to 29% (tHcy) of the 
biomarker variability. We observed significant associations for most biomarkers (≥6 out of 8) with 
age, sex, race-ethnicity, supplement use, smoking, and BMI; and for some biomarkers with PIR 
(5/8), education (1/8), alcohol consumption (4/8), and physical activity (5/8). We noted large 
estimated percent changes in biomarker concentrations between race-ethnic groups (from −24% to 
20%), between supplement users and nonusers (from −12% to 104%), and between smokers and 
nonsmokers (from −28% to 8%). In summary, age, sex, and race-ethnic differentials in biomarker 
concentrations remained significant after adjusting for sociodemographic and lifestyle variables. 
Supplement use and smoking were important correlates of biomarkers of WSV status.
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INTRODUCTION
The water-soluble B vitamins folate, B-6 and B-12 are important cofactors in one-carbon 
metabolism, participating in methylation reactions and DNA synthesis (1). Vitamin C 
functions as a water-soluble antioxidant due to its high reducing power. Its best 
characterized function is in the synthesis of collagen connective tissue protein through the 
hydroxylation of proline and lysine residues of procollagen (2). While clinical deficiencies 
are rare for these vitamins, interest in these nutrients persists; “suboptimal” folate status is 
known to increase the risk of neural tube defects (3), vitamin C in combination with other 
supplements (vitamin E, zinc, and beta-carotene) has been shown to slow the progression of 
age-related macular degeneration (4), and “suboptimal” vitamin B or C status may modulate 
chronic diseases such as cardiovascular disease, cancer, and/or cognitive function (5,6). 
Furthermore, in the era of post-folic acid fortification, public health concerns are no longer 
limited to low folic acid intakes, but extend to the safety of high intakes (7), which are 
largely driven by supplement use (8).
Different biochemical indicators have been measured in the US population as part of the 
NHANES 2003–2006 to assess the status of water-soluble vitamins. The CDC’s Second 
National Report on Biochemical Indicators of Diet and Nutrition in the US Population 
(Second Nutrition Report) used these data to provide a descriptive analysis of the nutritional 
status of Americans by age, sex, and race-ethnicity. These analyses however, provide only 
limited interpretation of relative differences in nutritional status by demographic subgroup 
(9).
The relationship between diet and health is of great public health interest. Nutritional 
biomarkers are considered mediators of this relationship, avoiding reliance on biased self-
reports of diet (10,11). Aside from diet, various genetic, biological, and lifestyle variables 
influence biomarkers. However, the associations between these variables and biomarkers are 
understudied. Data from national nutrition surveys in the United States, United Kingdom, 
Canada, and Mexico have shown that socioeconomic status and/or lifestyle variables are 
related to nutritional biomarkers (Table 1). Most of these studies were limited in scope, 
investigating the influence of 1 or few variables on 1 or 2 biomarkers (12–30). Few studies 
have assessed the relationship of multiple biomarkers with socioeconomic variables (31,32), 
smoking (33), alcohol consumption (34), or BMI (35,36). To our knowledge, no studies have 
examined the combined association of sociodemographic and lifestyle variables with 
biomarkers of water-soluble vitamin status.
To fill this knowledge gap and in order to examine whether demographic differentials in 
nutritional status found in the Second Nutrition Report were confounded by certain 
variables, we applied a systematic modeling approach to questionnaire and laboratory data 
from the adult US population participating in NHANES 2003–2006 to assess the association 
of 10 preselected sociodemographic (age, gender, race-ethnicity, education, and income) and 
lifestyle (supplement use, smoking, alcohol consumption, BMI, and physical activity) 
variables with 8 biomarkers of water-soluble vitamin status. These results will provide a 
foundation to researchers who develop predictive regression models addressing specific 
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hypotheses. Companion publications in this journal supplement address the same questions 
for other biomarker classes featured in the Second Nutrition Report.
SUBJECTS AND METHODS
The NHANES, designed and carried out by the National Center for Health Statistics 
(NCHS) 5 at CDC, collects cross-sectional data on the health and nutritional status of the 
civilian non-institutionalized US population (37). Since 1999, it has been conducted as a 
continuous survey with data released in 2-y cycles. The 2003–2006 survey cycles obtained a 
stratified, multistage, probability sample designed to represent the American population on 
the basis of age, sex, and race/ethnicity. Data collection consisted of a screening visit, during 
which sample persons were identified; an interview during which a wide battery of health 
related questions were asked; and an examination consisting of direct standardized physical 
examinations, including body measurements and blood and urine collection, carried out in a 
mobile examination center. All respondents gave their informed consent, and the NHANES 
protocol was reviewed and approved by the NCHS Research Ethics Review Board. Interview 
and examination response rates for each survey period are publically available (38).
Laboratory methods
The following biomarkers were analyzed by the CDC laboratory during all or part of 
NHANES 2003–2006: serum (S-FOL; short-term indicator) and RBC folate (RBC-FOL; 
long-term indicator), and plasma total homocysteine (tHcy; functional indicator of 
“suboptimal” folate, riboflavin, B-6, or B-12 status); serum pyridoxal-5′-phosphate (PLP; 
biologically active coenzyme form and best single indicator of vitamin B-6 status; 2005–
2006 only) and serum 4-pyridoxic acid (4PA; end product of vitamin B-6 catabolism and 
indicator of recent intake; 2005–2006 only); serum total cobalamin (B-12) and plasma 
methylmalonic acid (MMA; functional indicator of “suboptimal” vitamin B-12 status; 2003–
2004 only); and serum ascorbic acid (VIC; indicator of tissue stores). Information for each 
biomarker on the specimen matrix, the NHANES survey period assessed, and the laboratory 
method used is presented in Supplemental Table 1. Laboratory method details are provided 
elsewhere (39,40). Westgard-type QC multi-rules were used to judge assay performance 
(41).
Study variables
Data for all sociodemographic variables (age, sex, race-ethnicity, income, and education) 
and several lifestyle variables (alcohol consumption, physical activity level and supplement 
use) used in our analysis were self-reported. For bivariate analyses, we categorized the 
variables as follows: age (20–39 y, 40–59 y, and ≥60 y); sex (men and women); race-
ethnicity (Mexican American [MA], non-Hispanic black [NHB], and non-Hispanic white 
[NHW]); education (<high school, high school, and >high school); family poverty income 
ratio (PIR: 0–1.85 [low], >1.85–3.5 [medium], and >3.5 [high]) (42); smoking (serum 
cotinine ≤10 μg/L [nonsmoker], >10 μg/L [smoker]) (43); alcohol consumption (average 
daily number of “standard” drinks [1 drink ≈ 15 g ethanol]: no drinks, <1 (not 0), 1–<2, and 
≥2 drinks/d); BMI (kg/m2: <18.5 [underweight], 18.5–<25 [normal], 25–<30 [overweight], 
and ≥30 [obese]) (44); physical activity (total metabolic equivalent task [MET]-min/wk from 
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leisure time physical activity; none reported, 0–<500, 500–<1000, and ≥1000 MET-min/wk) 
(45); supplement use (reported taking a dietary supplement within the past 30 d: yes [user], 
no [non-user]).
Analytic sample
All participants examined in the mobile examination center aged 20 y and older in the 
NHANES 2003–2004 and 2005–2006 with at least 1 biomarker of interest were eligible for 
inclusion in the analysis. Depending on whether the biomarker was analyzed in both survey 
periods or just in 1 survey period, data were available for between ~4300 and nearly 9000 
adult NHANES participants (Supplemental Table 2). We did not exclude participants 
because our intent was to assess how these variables impact the general US population. 
Furthermore, considering all the potentially relevant exclusions in an analysis with such 
broad scope of biomarkers would have been impractical. However, we verified that 
excluding participants who reported to have used antibiotics in the last 30 d (~0.4% of 
participants) did not substantially alter the geometric mean of the two biomarkers of vitamin 
B-6 status PLP and 4PA compared to not excluding them.
Statistical methods
As we used the same statistical methods for the series of papers presented in this 
supplement, the reader is referred to Sternberg et al. (46) for a detailed description of the 
methods and for a discussion of compromises taken in developing the multiple regression 
model due to the limited degrees of freedom, such as the number of covariates considered, 
the chosen form of continuous covariates, and the consideration of interactions between 
covariates. In short, we explored bivariate associations between each biomarker and selected 
study variables by calculating Spearman correlations (for continuous variables) and by 
presenting the geometric means (arithmetic mean for VIC as its distribution was reasonably 
symmetric) and 95% CI across the variable categories.
We used multiple linear regression to assess the impact of confounding and determine 
whether statistical significance persists after adjusting for differences in key variables. We 
arranged the independent variables into 2 sets or “chunks”: 1) sociodemographic variables 
(age, sex, race-ethnicity, education level, and PIR) and 2) lifestyle variables (dietary 
supplement use, smoking, alcohol consumption, BMI, and physical activity level). We tested 
each chunk simultaneously to determine whether the independent variables (as a group) 
were related to the dependent variable; followed by a test for each individual variable while 
controlling for the other variables. We present the results of 3 regression models for each 
biomarker: simple linear regression (model 1), multiple linear regression model with the 
sociodemographic chunk (model 2), and multiple linear regression model with both the 
sociodemographic and lifestyle chunk (model 3). This allows for the comparison of results 
across all biomarkers. For each model we present the estimated percent change (absolute 
unit change for VIC) in biomarker concentrations with change in each covariate holding all 
other remaining covariates constant. Two-sided P-values were flagged as statistically 
significant if <0.05.
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RESULTS
A description of the civilian non-institutionalized US population by the variables studied 
using NHANES 2003–2006 can be found in Supplemental Table 3. Most of the continuous 
variables (age, PIR, smoking, alcohol consumption, BMI, and exercise duration) were at best 
moderately significantly correlated (|r| ≤0.43) with the biomarkers of water-soluble vitamin 
status; MMA showed a moderate significant correlation with age only (r = 0.33) (Table 2). 
Based on the magnitude of the statistically significant Spearman correlations, age and 
smoking were generally the strongest correlates of biomarker concentrations, with levels 
increasing with increasing age and decreasing with increasing exposure to cigarette smoking 
(except for tHcy which was positively correlated to smoking).
Bivariate methods (model 1) were used to test for significant differences among variable 
categories. Of the demographic variables, age (except for PLP), sex (except for 4PA and 
B-12) and race-ethnicity (except for VIC) were significantly associated with most 
biomarkers, with age and race-ethnicity, separately, accounting for the largest variability in 
most biomarkers (Table 3). The socioeconomic variables education (except for B-12 and 
MMA) and PIR (except for B-12, tHcy and MMA) were also significantly associated with 
most biomarkers, but other than for PLP, they did not account for much of the variability in 
biomarker concentration. All 5 lifestyle variables were significantly associated with all 
biomarker concentrations, except for MMA, which was only significantly associated with 
alcohol consumption and physical activity (Table 4). Supplement use and smoking, 
separately, accounted for the largest variability in biomarker concentrations, while the other 
3 variables explained only little of the biomarker variability.
In multiple regression models, the chunk of sociodemographic variables (model 2) explained 
up to 27% of the variability in biomarker concentrations: 2% (B-12), 6% (PLP), 8% (VIC), 
13% (4PA and MMA), 14% (S-FOL), 15% (RBC-FOL), and 27% (tHcy) (Supplemental 
Table 4). Together, the chunks of sociodemographic and lifestyle variables (model 3) 
explained up to 29% of the variability: 7% (B-12), 15% (MMA), 22% (VIC), 23% (PLP), 
25% (4PA), 26% (S-FOL and RBC-FOL), and 29% (tHcy). Adjusting for sociodemographic 
variables generally led to a mild attenuation of beta coefficients, while additionally adjusting 
for lifestyle variables more acutely diminished the association with sociodemographic 
variables, suggesting that sociodemographic variables may capture some unmeasured 
association that was shared with lifestyle variables.
Because the log transformations may obscure the interpretation of the beta coefficients, we 
estimated the percent change in biomarker concentrations (change in μmol/L for VIC which 
was not log transformed) associated with each covariable (Table 5). As noted with the beta 
coefficients, the estimated effect of most of these variables changed between models 1 and 3, 
suggesting that at least some of the association measured in the unadjusted model may be a 
result of confounding with variables not included in the model. For example, the estimated 
percent change for S-FOL concentrations for persons who were older by 10 y fell from 9.9% 
in model 1 to 6.8% in model 3, for women vs. men from 13.8% to 5.8%, and for NHB vs. 
NHW from −23.6% to −13.0%. Based on the full regression model 3, we observed 
significant associations for most biomarkers with age (8/8), sex (8/8), race-ethnicity (6/8 for 
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NHB vs. NHW and 7/8 for MA vs. NHW), supplement use (8/8), smoking (7/8), and BMI 
(6/8); and for some biomarkers with PIR (5/8), education (1/8), alcohol consumption (4/8), 
and physical activity (5/8) (for a graphic representation, see also Supplemental Fig. 1–4). 
Age (being 10 y older) showed the strongest association with 4PA (15%), tHcy (10%), and 
MMA (9%); sex (being a women) with PLP (−21%), tHcy (−15%), and VIC (5.7 μmol/L); 
and race-ethnicity (being MA or NHB vs. NHW) with 4PA (−24% and −13%, respectively), 
MMA (−22% and −22%, respectively), and B-12 (20% and 15%, respectively). Supplement 
use and smoking both showed the strongest association with biomarkers of vitamin B-6 
status (4PA 104% and −18%, PLP 79% and −28%, respectively), biomarkers of folate status 
(S-FOL 38% and −15%, RBC-FOL 24% and −12%, respectively), and VIC (16 and −11 
μmol/L, respectively). Estimated vitamin concentrations in supplement users were up to 
twice as high compared to nonusers. As expected, the inversely correlated metabolites Hcy 
and MMA showed lower estimated concentrations in supplement users. Estimated vitamin 
concentrations in smokers were up to ~30% lower and tHcy concentrations were nearly 10% 
higher.
DISCUSSION
Using cross-sectional data for biomarkers of water-soluble vitamin status from a nationally 
representative sample of American adults participating in NHANES 2003–2006, we found 
that 1) age, sex, and race-ethnic differentials in biomarker concentrations remained 
significant, though the magnitude of the differentials was generally diminished after 
adjusting for key sociodemographic and lifestyle variables; and 2) of the variables studied, 
supplement use, smoking, and race-ethnicity were important correlates of biomarkers of 
water-soluble vitamin status, independent of the other sociodemographic and lifestyle 
variables in the model.
We used 3 different approaches to study the association between biomarkers and variables––
correlations, bivariate regression, and multiple regression models and found good 
consistency across these approaches. Age and smoking emerged as the strongest individual 
correlates of the biomarkers. Using bivariate methods, age, race-ethnicity, supplement use, 
and smoking accounted for the largest portions of the variability in biomarker 
concentrations. Finally, using multiple regression models, age, sex, race-ethnicity, 
supplement use, and smoking continued to be significantly associated with nearly all 
biomarkers.
Our modeling estimated 79% higher PLP concentrations in supplement users compared to 
nonusers; this large difference can also be observed when comparing the prevalence of low 
PLP (<20 nmol/L) in supplement users (7.8%) compared to nonusers (19%) (data not 
shown). Morris et al. found similar prevalence estimates (11% in supplement users and 24% 
in nonusers) in NHANES 2003–2004 after adjusting for a similar list of variables plus self-
reported diabetes status and intakes of protein and energy (19). Our analysis estimated S-
FOL and RBC-FOL concentrations to be 39% and 24% higher, respectively in supplement 
users, similar to a recent NHANES 1999–2010 report (41% and 33% higher, respectively) 
(13). The larger proportional increase in S-FOL compared to RBC-FOL as a result of a 
folate dose––also noted after the introduction of folic acid fortification (13) and in response 
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to long-term folic acid supplementation (47)—is likely a result of the much higher RBC 
folate concentration compared to serum. We estimated 21% higher B-12 concentrations in 
supplement users compared to nonusers, which is consistent with a prevalence of low B-12 
(<200 ng/L) of 2.0% in supplement users compared to 3.1% in non-users (data not shown). 
Evatt et al. found a slightly bigger difference in low B-12 prevalence between users (1.7%) 
and nonusers (3.9%) for persons 18 y and older in NHANES III, however they assessed 
specifically B-12-containing supplement consumption (20). Our analysis estimated VIC 
concentrations to be 16.4 μmol/L higher in supplement users. Schleicher et al. found age-
adjusted VIC concentrations to be 25 μmol/L higher in adults who consumed vitamin C-
containing supplements as part of NHANES 2003–2004 (23).
Smoking was also significantly related in our analysis with most biomarkers, with smokers 
having lower vitamin concentrations compared to nonsmokers: VIC (~30%), PLP (29%), 
4PA (18%), S-FOL (16%), and RBC-FOL (13%). Schleicher et al. reported 30% (men) and 
33% (women) lower age-adjusted VIC concentrations for smokers vs. nonsmokers (23). 
Morris et al. showed that adjusted PLP concentrations of current smokers compared to those 
who never smoked were 25% and 22% lower in supplement users and nonusers, respectively 
(19). Using data from NHANES III, Mannino et al. found adjusted (sociodemographic 
variables and folate intake) RBC-FOL concentrations to be 16% lower in smokers compared 
to nonsmokers with low exposure to passive smoking (16). As expected due to the inverse 
relationship of tHcy with folate, vitamin B-6 and B-12, we found higher estimated tHcy 
concentrations (8%) in smokers. Similar observations were made in previous analyses of the 
US population (25,26,28,29). The 1994/1995 British National Diet and Nutrition Survey 
(NDNS) of people aged 65 y and over found an inverse relationship between smoking status 
and nutrient intake (VIC, B-6, and folate) and between smoking status and micronutrient 
indices (VIC, PLP, S-FOL, and RBC-FOL) after adjusting for intake and other covariates 
(33). Smoking itself may predispose to lower water-soluble vitamin status. In a recent 
analysis from two large Norwegian B vitamin intervention trials (NORVIT and WENBIT), 
Ulvik et al. showed that smoking status was directly associated with tHcy and inversely with 
S-FOL and PLP in a dose-response relationship (48). More interestingly, smokers with low 
serum cotinine (abstained from smoking for ≥3 d) had higher S-FOL and PLP 
concentrations compared to smokers with high serum cotinine. The authors suggested that 
the short-term effects may be related to acute smoking-induced oxidative stress; long-term 
effects among ex-smokers may reflect changes in diet and/or restoration of vitamin 
concentrations in tissue after smoking cessation.
Our analysis also showed a significant relation between race-ethnicity and most biomarkers. 
Compared to NHW, MA and NHB had lower S-FOL, RBC-FOL, 4PA, and MMA, but 
higher B-12 and VIC. Similar race-ethnic differentials were found in previous descriptive 
analyses of the US population (13,19,49), but also in an analysis by Kant et al. after they 
adjusted for socioeconomic status (and additionally for nutrient-specific intake) (32). The 
authors found lower folate intake and status in NHB, both pre- and post-fortification and 
suggested that ethnic-specific nutrition interventions would be needed to target at-risk ethnic 
groups and promote dietary changes. However, given the different frequencies of the 
MTHFR C677T genotype among the three major race-ethnic groups (50) and the fact that 
the BioRad radioassay—used in NHANES 1988–1994 and 1999–2006—responded 
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differently to blood samples with the T/T genotype compared with either C/C or C/T 
genotypes (13), the association between RBC-FOL and race-ethnicity needs to be 
interpreted with caution. While we generally observed attenuation of the effect of race-
ethnicity on biomarker concentrations with increasing adjustment, this was not the case for 
VIC. After adjusting for lifestyle variables, NHB had significantly higher VIC 
concentrations compared to NHW, whereas prior to adjustment the opposite was true, which 
may suggest confounding with at least 1 of the lifestyle variables, assuming the model is not 
misspecified.
Other sociodemographic or lifestyle variables assessed in this analysis had generally weaker 
and in some cases nonsignificant associations with biomarkers. After adjusting for 
sociodemographic and lifestyle variables, age was positively correlated with most 
biomarkers (negatively correlated with PLP) and women had better folate and vitamin C 
status, but lower vitamin B-6 and B-12 status, compared to men. Similar age and sex 
differences were reported in previous NHANES analyses (9,13,19,23,29,49,51). We 
confirmed previous findings of lower S-FOL (17,18,35,36) and higher RBC-FOL (18) 
concentrations with higher BMI. However, Tinker et al. only found BMI inversely associated 
with S-FOL among women who did not use folic acid-containing supplements, 
hypothesizing that cellular uptake and tissue distribution of folate may be altered by BMI 
which may be compensated by folic acid supplement use (18). Similar to findings by 
Walmsley et al. from the British NDNS (34), we also noted higher estimated PLP 
concentrations with higher alcohol consumption and no (RBC-FOL, 4PA, MMA, and VIC) 
or minimal (slightly lower S-FOL and B-12 and slightly higher tHcy) changes in all other 
biomarkers. This is expected based on results from a randomized intervention study of 
moderate alcohol consumption in postmenopausal women, which showed no (S-FOL, 
MMA) or small (B-12, tHcy) effects of 1 or 2 drinks/d over an 8-wk period (52).
To our knowledge, this is the first study that examined the association of demographic, 
socioeconomic, and lifestyle variables with all biomarkers available in the more recent 
continuous NHANES to interpret the status of 4 water-soluble vitamins: folate, vitamins 
B-6, B-12, and C. By applying a systematic modeling approach and limiting data driven 
decisions in the model building process we preserved the statistical properties of P-values 
and coefficients (46). Additionally, the hierarchical chunk regression modeling provided a 
natural way to systematically assess the magnitude of an estimated change in biomarker 
concentration with a change in a single covariate, holding all other variables constant, across 
biomarkers. Moreover, we applied the same approach to other classes of nutritional and 
dietary biomarkers allowing comparisons over a wide range of indicators (see other papers 
in this journal supplement; a summary table is presented in [46]). The large sample size in 
NHANES in combination with the use of 2 survey cycles that maximized the number of 
available biomarkers (i.e., tHcy, MMA, and VIC data are not available after 2006) allowed 
us to assess associations with a fair number of covariates in the same model.
Our analysis has limitations. The cross-sectional nature of NHANES prevented us from 
drawing any causal relationships between the biomarkers and variables in our study. Our 
results could be confounded by unmeasured biological and genetic factors. We did not test 
for interactions between variables due to limitations in degrees of freedom, nor did we 
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maximize the predictive power of our descriptive model. Investigating nutrient-nutrient 
interactions (e.g., vitamin B-6 and protein intake, vitamin C and iron), studying how various 
health conditions or health risk factors are associated with nutritional biomarkers, or how 
dietary intake or intake of specific dietary supplements are associated with nutritional 
biomarkers or interact with variables included in our analysis was outside the scope of this 
study. Nutrient intake is known to be a major determinant of biomarker concentrations and 
both intake and biomarkers are indicators of nutritional status. We chose to describe how 
biomarkers were associated with certain variables after adjusting for sociodemographic and 
lifestyle variables and within that scheme dietary intake was more naturally an outcome 
variable than a covariate. A few studies have shown that associations of biomarkers with 
different variables remained unchanged after addition of the relevant nutrient intake to 
regression models (16,17,32,33). Regardless, our descriptive analysis cannot answer the 
question whether the associations we found are explained by intake or not. In summary, we 
conclude that supplement use, smoking, and race-ethnicity were associated with notable 
changes in concentrations of most biomarkers of water-soluble vitamin status, after adjusting 
for preselected sociodemographic and lifestyle variables. This analysis provides a 
foundation for future data analyses that set out to build predictive models to address specific 
hypotheses between nutritional status and health.
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Table 1
National nutrition surveys that assessed the association between socioeconomic and lifestyle variables and 
biochemical indicators or water-soluble vitamin status in adult populations
Biochemical indicator(s)1 (specimen 
matrix)2
Variable(s)
(socioeconomic and/or lifestyle) National nutrition survey
3 Reference
FOL (S, RBC) Education NHANES III 12
FOL (S, RBC) Income, supplement use NHANES III and 1999–2010 13
FOL (S) Supplement use NHANES 2001–2004 14
FOL (RBC) Income, education, supplement use Canadian HMS 15
FOL (S, RBC) Smoking NHANES III 16
FOL (S) BMI NHANES III and 1999–2000 17
FOL (S, RBC) BMI, supplement use NHANES 2003–2008 18
PLP (P) Supplement use, smoking, alcohol consumption, 
BMI
NHANES 2003–2004 19
B-12 (S) Supplement use NHANES III 20
B-12 (S) Income and BMI Canadian HMS 21
VIC (S) Smoking NHANES III 22
VIC (S) Income, supplement use, smoking, BMI NHANES 2003–2004 23
tHcy (P) Income, education NHANES 1999–2002 24
tHcy (P) Smoking (passive) NHANES III 25
tHcy (P) Smoking (passive) NHANES 1999–2002 26
tHcy (P) Smoking, BMI British NDNS 27
tHcy (P) Supplement use, smoking, alcohol consumption, 
BMI
NHANES III 28
tHcy (P) Supplement use, smoking, BMI NHANES 1999–2004 29
MMA (P) Income, social class, education, smoking, physical 
activity
British NDNS 30
FOL (RBC), VIC (S), other MN Income Mexican National Survey 31
FOL (S, RBC), VIC (S), other MN Income, education NHANES III and 1999–2002 32
FOL (S, RBC), PLP (P), B-12 (S), VIC 
(P), other MN
Smoking British NDNS 33
FOL (S, RBC), PLP (P), VIC (P), other 
MN
Alcohol consumption British NDNS 34
FOL (S, RBC), VIC (S), other MN BMI NHANES III 35
FOL (S, RBC), B-12 (S), VIC (S), other 
MN
BMI NHANES III 36
14PA, 4-pyridoxic acid; B-12, total cobalamin; FOL, folate; MMA, methylmalonic acid; MN, micronutrients; PLP, pyridoxal-5′-phosphate; tHcy, 
total homocysteine; VIC, ascorbic acid
2S, serum; P, plasma
3US National Health and Nutrition Examination Survey; Canadian Health Measures Survey; British National Diet and Nutrition Survey
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(12
.2 
– 1
3.1
)
28
7
(28
0 –
 29
4)
52
.5
(48
.9 
– 5
6.3
)
40
.9
(38
.0 
– 4
4.0
)
45
4
(44
1 –
 46
8)
8.
39
(8.
22
 – 
8.5
7)
14
6
(13
9 –
 15
4)
54
.9
(52
.9 
– 5
6.9
)
 
P-
va
lu
e
<
0.
00
01
<
0.
00
01
<
0.
00
01
<
0.
00
01
<
0.
00
01
<
0.
00
01
<
0.
00
01
0.
18
 
r2
,
 
%
4
7
1
4
1
2
4
<
1
Ed
uc
at
io
n
 
<
H
ig
h 
sc
ho
ol
10
.7
(10
.3 
– 1
1.1
)
25
2
(24
6 –
 25
8)
39
.6
(36
.8 
– 4
2.7
)
29
.0
(26
.6 
– 3
1.7
)
47
1
(45
5 –
 48
8)
8.
50
(8.
17
 – 
8.8
4)
14
5
(13
3 –
 15
7)
48
.6
(46
.5 
– 5
0.7
)
 
H
ig
h 
sc
ho
ol
11
.7
(11
.2 
– 1
2.1
)
26
7
(26
0 –
 27
5)
45
.2
(42
.4 
– 4
8.3
)
33
.6
(30
.1 
– 3
7.5
)
45
7
(44
3 –
 47
2)
8.
49
(8.
30
 – 
8.6
8)
13
9
(13
0 –
 14
8)
50
.5
(48
.9 
– 5
2.1
)
 
>
H
ig
h 
sc
ho
ol
12
.4
(12
.0 
– 1
2.9
)
27
9
(27
3 –
 28
5)
56
.3
(52
.6 
– 6
0.4
)
38
.9
(35
.9 
– 4
2.2
)
46
7
(45
5 –
 47
9)
8.
00
(7.
87
 – 
8.1
3)
13
7
(13
1 –
 14
3)
57
.3
(55
.6 
– 5
9.0
)
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Va
ri
ab
le
S-
FO
L
μg
/L
R
BC
-F
O
L
μg
/L
PL
P
n
m
o
l/L
4P
A
n
m
o
l/L
B-
12
n
g/
L
tH
cy
μm
ol
/L
M
M
A
n
m
o
l/L
V
IC
μm
ol
/L
 
P-
va
lu
e
<
0.
00
01
<
0.
00
01
<
0.
00
01
<
0.
00
01
0.
24
<
0.
00
01
0.
19
<
0.
00
01
 
r2
,
 
%
1
1
3
1
0
1
<
1
2
PI
R
7
 
Lo
w
10
.8
(10
.6 
– 1
1.1
)
25
4
(24
9 –
 25
9)
40
.2
(38
.1 
– 4
2.4
)
28
.8
(26
.8 
– 3
1.0
)
46
1
(45
1 –
 47
2)
8.
22
(8.
01
 – 
8.4
3)
13
9
(13
0 –
 14
8)
49
.2
(47
.4 
– 5
1.1
)
 
M
ed
iu
m
12
.0
(11
.5 
– 1
2.6
)
27
3
(26
6 –
 28
1)
48
.6
(44
.3 
– 5
3.2
)
33
.4
(30
.1 
– 3
7.2
)
46
8
(45
0 –
 48
6)
8.
29
(8.
11
 – 
8.4
8)
14
0
(13
2 –
 14
9)
53
.6
(51
.6 
– 5
5.6
)
 
H
ig
h
12
.6
(12
.2 
– 1
3.0
)
28
3
(27
6 –
 28
9)
58
.5
(55
.4 
– 6
1.9
)
41
.7
(38
.7 
– 4
4.9
)
46
4
(45
0 –
 47
8)
8.
13
(7.
98
 – 
8.2
9)
13
9
(13
2 –
 14
6)
57
.6
(55
.9 
– 5
9.3
)
 
P-
va
lu
e
<
0.
00
01
<
0.
00
01
<
0.
00
01
<
0.
00
01
0.
73
0.
16
0.
91
<
0.
00
01
 
r2
,
 
%
1
1
3
2
0
0
0
1
1 B
io
m
ar
ke
r 
co
n
ce
n
tr
at
io
ns
 re
pr
es
en
t g
eo
m
et
ric
 m
ea
ns
 (a
rit
hm
eti
c m
ea
n f
or 
vit
am
in 
C)
 an
d 9
5%
 C
I; 
4P
A
, 4
-p
yr
id
ox
ic
 a
ci
d;
 B
-1
2,
 to
ta
l c
ob
al
am
in
; M
M
A
, m
et
hy
lm
al
on
ic
 a
ci
d;
 P
LP
,
 
py
rid
ox
al
-5
′-p
ho
sp
ha
te
; 
R
B
C-
FO
L,
 R
BC
 fo
la
te
; S
-F
O
L,
 se
ru
m
 fo
la
te
; t
H
cy
,
 
to
ta
l h
om
oc
ys
te
in
e;
 V
IC
, a
sc
or
bi
c 
ac
id
. S
I c
on
v
er
sio
n 
fa
ct
or
s 
ar
e 
as
 fo
llo
w
s:
 F
O
L,
 ×
2.
26
6 
(nm
ol/
L)
 an
d B
-12
, ×
0.7
38
 (p
mo
l/L
)
2 M
M
A
 d
at
a 
on
ly
 av
ai
la
bl
e 
fo
r N
H
A
N
ES
 2
00
3–
20
04
; P
LP
 a
nd
 4
PA
 d
at
a 
on
ly
 av
ai
la
bl
e 
fo
r N
H
A
N
ES
 2
00
5–
20
06
3 S
am
pl
e 
siz
es
 fo
r e
ac
h 
bi
om
ar
ke
r 
by
 v
ar
ia
bl
e 
ca
n 
be
 fo
un
d 
in
 S
up
pl
em
en
ta
l T
ab
le
 2
4 P
-
v
al
ue
 b
as
ed
 o
n 
W
al
d 
F 
te
st,
 w
hi
ch
 te
sts
 w
he
th
er
 a
t l
ea
st 
on
e 
of
 th
e 
m
ea
ns
 a
cr
os
s t
he
 c
at
eg
or
ie
s i
s s
ig
ni
fic
an
tly
 d
iff
er
en
t
5 r
2  
ba
se
d 
on
 m
od
el
 1
, s
im
pl
e 
lin
ea
r r
eg
re
ss
io
n,
 u
sin
g 
ca
te
go
rie
s a
s s
ho
w
n
6 M
A
, M
ex
ic
an
 A
m
er
ic
an
; N
H
B,
 n
on
-H
isp
an
ic
 b
la
ck
; N
H
W
,
 
n
o
n
-H
isp
an
ic
 w
hi
te
7 P
IR
, f
am
ily
 p
ov
er
ty
 in
co
m
e 
ra
tio
: 0
–1
.8
5 
(lo
w
); 
>1
.85
–3
.5 
(m
ed
ium
); 
>3
.5 
(hi
gh
)
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Ta
bl
e 
4
U
na
dju
ste
d b
iom
ark
er
 c
o
n
ce
n
tr
at
io
ns
 o
f w
at
er
-
so
lu
bl
e 
vi
ta
m
in
 st
at
us
 b
y 
lif
es
ty
le
 v
ar
ia
bl
e 
ca
te
go
rie
s f
or
 a
du
lts
 ≥
20
 y,
 
N
H
A
N
ES
 2
00
3–
20
06
1,
2,
3
Va
ri
ab
le
S-
FO
L
μg
/L
R
BC
-F
O
L
μg
/L
PL
P
n
m
o
l/L
4P
A
n
m
o
l/L
B-
12
n
g/
L
tH
cy
μm
ol
/L
M
M
A
n
m
o
l/L
V
IC
μm
ol
/L
Su
pp
le
m
en
t u
se
4
 
N
o
9.
37
(9.
13
 – 
9.6
2)
23
1
(22
6 –
 23
5)
36
.0
(34
.2 
– 3
7.9
)
22
.2
(21
.0 
– 2
3.5
)
42
1
(41
0 –
 43
1)
8.
43
(8.
27
 – 
8.5
9)
14
1
(13
4 –
 14
8)
42
.6
(40
.7 
– 4
4.5
)
 
Ye
s
14
.5
(14
.1 
– 1
5.0
)
31
0
(30
4 –
 31
7)
66
.2
(62
.9 
– 6
9.7
)
53
.0
(48
.9 
– 5
7.5
)
50
5
(49
1 –
 52
0)
8.
04
(7.
86
 – 
8.2
3)
13
7
(12
9 –
 14
4)
63
.5
(62
.2 
– 6
4.9
)
 
P-
va
lu
e5
<
0.
00
01
<
0.
00
01
<
0.
00
01
<
0.
00
01
<
0.
00
01
<
0.
00
01
0.
11
<
0.
00
01
 
r2
,
 
%
6
17
15
12
17
4
<
1
<
1
13
Sm
ok
in
g7
 
N
o
12
.9
(12
.5 
– 1
3.3
)
28
7
(28
2 –
 29
3)
55
.0
(52
.2 
– 5
7.9
)
39
.5
(36
.4 
– 4
2.8
)
47
8
(46
6 –
 49
0)
8.
02
(7.
87
 – 
8.1
6)
13
9
(13
3 –
 14
5)
58
.8
(57
.5 
– 6
0.0
)
 
Ye
s
9.
77
(9.
49
 – 
10
.1)
23
4
(22
9 –
 23
9)
39
.5
(36
.5 
– 4
2.8
)
27
.3
(24
.8 
– 3
0.0
)
43
3
(42
1 –
 44
5)
8.
73
(8.
49
 – 
8.9
7)
13
7
(12
8 –
 14
7)
42
.1
(40
.2 
– 4
4.1
)
 
P-
va
lu
e
<
0.
00
01
<
0.
00
01
<
0.
00
01
<
0.
00
01
<
0.
00
01
<
0.
00
01
0.
65
<
0.
00
01
 
r2
,
 
%
6
6
3
2
1
1
0
7
A
lc
oh
ol
 c
on
su
m
pt
io
n8
 
N
o 
dr
in
ks
12
.7
(12
.2 
– 1
3.3
)
28
0
(27
2 –
 28
8)
46
.6
(43
.2 
– 5
0.2
)
38
.6
(35
.0 
– 4
2.6
)
47
7
(46
0 –
 49
5)
8.
51
(8.
22
 – 
8.8
2)
14
9
(13
8 –
 16
0)
54
.8
(52
.8 
– 5
6.8
)
 
<
1 
(no
t 0
)
11
.8
(11
.5 
– 1
2.2
)
27
1
(26
5 –
 27
6)
50
.0
(47
.1 
– 5
3.0
)
34
.9
(32
.6 
– 3
7.4
)
46
3
(45
1 –
 47
5)
7.
91
(7.
77
 – 
8.0
4)
13
4
(12
9 –
 14
0)
55
.1
(53
.4 
– 5
6.8
)
 
1–
<2
11
.4
(10
.6 
– 1
2.1
)
26
3
(25
3 –
 27
4)
62
.8
(54
.9 
– 7
1.9
)
38
.4
(32
.3 
– 4
5.7
)
43
8
(42
4 –
 45
2)
8.
66
(8.
40
 – 
8.9
3)
13
5
(12
7 –
 14
3)
51
.0
(47
.1 
– 5
4.9
)
 
≥2
10
.2
(9.
58
 – 
10
.9)
25
6
(24
3 –
 26
9)
59
.5
(52
.1 
– 6
7.9
)
32
.8
(28
.3 
– 3
7.9
)
44
6
(42
3 –
 47
0)
9.
35
(8.
89
 – 
9.8
3)
13
1
(12
0 –
 14
3)
45
.7
(41
.7 
– 4
9.7
)
 
P-
va
lu
e
<
0.
00
01
0.
01
11
<
0.
00
01
0.
03
61
0.
00
09
<
0.
00
01
0.
00
45
0.
00
01
 
r2
,
 
%
1
1
1
<
1
<
1
2
1
1
B
M
I9
 
U
nd
er
w
ei
gh
t
11
.7
(10
.6 
– 1
2.9
)
23
4
(21
2 –
 25
8)
46
.4
(36
.5 
– 5
8.9
)
27
.9
(21
.4 
– 3
6.5
)
52
0
(47
4 –
 57
2)
7.
88
(7.
32
 – 
8.5
0)
13
1
(11
6 –
 14
8)
57
.1
(51
.6 
– 6
2.5
)
 
N
or
m
al
 w
ei
gh
t
12
.3
(11
.9 
– 1
2.7
)
26
2
(25
5 –
 26
9)
56
.7
(52
.3 
– 6
1.5
)
37
.4
(33
.4 
– 4
1.8
)
48
1
(46
8 –
 49
5)
7.
94
(7.
76
 – 
8.1
2)
14
0
(13
1 –
 14
9)
59
.6
(57
.6 
– 6
1.7
)
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Va
ri
ab
le
S-
FO
L
μg
/L
R
BC
-F
O
L
μg
/L
PL
P
n
m
o
l/L
4P
A
n
m
o
l/L
B-
12
n
g/
L
tH
cy
μm
ol
/L
M
M
A
n
m
o
l/L
V
IC
μm
ol
/L
 
O
ve
rw
ei
gh
t
12
.3
(11
.9 
– 1
2.6
)
27
4
(26
9 –
 28
0)
57
.7
(55
.3 
– 6
0.2
)
40
.1
(37
.0 
– 4
3.5
)
47
3
(46
0 –
 48
7)
8.
43
(8.
25
 – 
8.6
2)
13
8
(13
2 –
 14
6)
55
.4
(53
.7 
– 5
7.2
)
 
O
be
se
11
.2
(10
.8 
– 1
1.7
)
27
9
(27
3 –
 28
4)
40
.2
(37
.1 
– 4
3.5
)
30
.9
(28
.6 
– 3
3.5
)
44
1
(42
6 –
 45
6)
8.
22
(8.
04
 – 
8.4
1)
13
7
(13
0 –
 14
4)
47
.4
(45
.7 
– 4
9.0
)
 
P-
va
lu
e
0.
00
01
<
0.
00
01
<
0.
00
01
<
0.
00
01
<
0.
00
01
<
0.
00
01
0.
60
<
0.
00
01
 
r2
,
 
%
1
1
4
1
1
1
0
3
Ph
ys
ic
al
 a
ct
iv
ity
10
 
N
on
e 
re
po
rte
d
11
.2
(10
.8 
– 1
1.5
)
26
1
(25
5 –
 26
8)
39
.3
(36
.7 
– 4
2.1
)
31
.9
(29
.7 
– 3
4.4
)
45
3
(44
0 –
 46
6)
8.
71
(8.
50
 – 
8.9
3)
14
8
(13
8 –
 15
8)
48
.0
(46
.3 
– 4
9.7
)
 
0–
<5
00
12
.1
(11
.7 
– 1
2.5
)
27
5
(26
9 –
 28
2)
50
.0
(47
.8 
– 5
2.4
)
34
.6
(32
.3 
– 3
7.1
)
46
3
(45
0 –
 47
5)
8.
04
(7.
83
 – 
8.2
4)
13
7
(13
0 –
 14
4)
53
.5
(51
.9 
– 5
5.0
)
 
50
0–
<1
00
0
12
.9
(12
.3 
– 1
3.5
)
28
5
(27
6 –
 29
4)
53
.4
(44
.9 
– 6
3.5
)
39
.9
(32
.0 
– 4
9.7
)
46
6
(44
9 –
 48
4)
7.
96
(7.
70
 – 
8.2
2)
13
5
(12
4 –
 14
7)
57
.9
(55
.7 
– 6
0.0
)
 
≥1
00
0
12
.1
(11
.6 
– 1
2.6
)
27
1
(26
5 –
 27
8)
62
.4
(58
.2 
– 6
6.9
)
38
.5
(34
.7 
– 4
2.7
)
47
9
(46
3 –
 49
6)
7.
94
(7.
80
 – 
8.0
8)
13
1
(12
7 –
 13
5)
59
.0
(56
.8 
– 6
1.2
)
 
P-
va
lu
e
<
0.
00
01
<
0.
00
01
<
0.
00
01
0.
00
25
0.
00
26
<
0.
00
01
<
0.
00
01
<
0.
00
01
 
r2
,
 
%
1
1
4
1
<
1
1
1
2
1 B
io
m
ar
ke
r 
co
n
ce
n
tr
at
io
ns
 re
pr
es
en
t g
eo
m
et
ric
 m
ea
ns
 (a
rit
hm
eti
c m
ea
n f
or 
vit
am
in 
C)
 an
d 9
5%
 C
I; 
4P
A
, 4
-p
yr
id
ox
ic
 a
ci
d;
 B
-1
2,
 to
ta
l c
ob
al
am
in
; M
M
A
, m
et
hy
lm
al
on
ic
 a
ci
d;
 P
LP
,
 
py
rid
ox
al
-5
′-p
ho
sp
ha
te
; 
R
B
C-
FO
L,
 R
BC
 fo
la
te
; S
-F
O
L,
 se
ru
m
 fo
la
te
; t
H
cy
,
 
to
ta
l h
om
oc
ys
te
in
e;
 V
IC
, a
sc
or
bi
c 
ac
id
. S
I c
on
v
er
sio
n 
fa
ct
or
s 
ar
e 
as
 fo
llo
w
s:
 F
O
L,
 ×
2.
26
6 
(nm
ol/
L)
 an
d B
-12
, ×
0.7
38
 (p
mo
l/L
)
2 M
M
A
 d
at
a 
on
ly
 av
ai
la
bl
e 
fo
r N
H
A
N
ES
 2
00
3–
20
04
; P
LP
 a
nd
 4
PA
 d
at
a 
on
ly
 av
ai
la
bl
e 
fo
r N
H
A
N
ES
 2
00
5–
20
06
3 S
am
pl
e 
siz
es
 fo
r e
ac
h 
bi
om
ar
ke
r 
by
 v
ar
ia
bl
e 
ca
n 
be
 fo
un
d 
in
 S
up
pl
em
en
ta
l T
ab
le
 2
4 “
Su
pp
le
m
en
t u
se
r”
 d
ef
in
ed
 a
s p
ar
tic
ip
an
t w
ho
 re
po
rte
d 
ta
ki
ng
 a
 d
ie
ta
ry
 su
pp
le
m
en
t w
ith
in
 th
e 
pa
st 
30
 d
5 P
-
v
al
ue
 b
as
ed
 o
n 
W
al
d 
F 
te
st,
 w
hi
ch
 te
sts
 w
he
th
er
 a
t l
ea
st 
1 
of
 th
e 
m
ea
ns
 a
cr
os
s t
he
 c
at
eg
or
ie
s i
s s
ig
ni
fic
an
tly
 d
iff
er
en
t
6 r
2  
ba
se
d 
on
 m
od
el
 1
, s
im
pl
e 
lin
ea
r r
eg
re
ss
io
n,
 u
sin
g 
ca
te
go
rie
s a
s s
ho
w
n
7 “
Sm
ok
er
” 
de
fin
ed
 b
y 
se
ru
m
 c
ot
in
in
e 
co
nc
en
tra
tio
n 
>1
0 
μg
/L
8 A
lc
oh
ol
 c
on
su
m
pt
io
n:
 c
al
cu
la
te
d 
as
 av
er
ag
e 
da
ily
 n
um
be
r o
f “
sta
nd
ar
d”
 d
rin
ks
 [(
qu
an
tity
 × 
fre
qu
en
cy
)/3
65
.25
]; 
1 d
rin
k ≈
 
15
 g
 et
ha
no
l
9 B
M
I (
kg
/m
2 )
 de
fin
iti
on
s: 
<1
8.
5 
(un
de
rw
eig
ht)
; 1
8.5
–>
25
 (n
orm
al 
we
igh
t);
 25
–<
30
 (o
v
er
w
ei
gh
t);
 an
d ≥
30
 (o
be
se)
10
Ph
ys
ic
al
 a
ct
iv
ity
: c
al
cu
la
te
d 
as
 to
ta
l m
et
ab
ol
ic
 e
qu
iv
al
en
t t
as
k 
(M
ET
)-m
in/
wk
 fr
om
 se
lf-
rep
ort
ed
 le
isu
re 
tim
e p
hy
sic
al
 a
ct
iv
iti
es
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Ta
bl
e 
5
Es
tim
at
ed
 c
ha
ng
e 
in
 b
io
m
ar
ke
r 
co
n
ce
n
tr
at
io
n 
of
 w
at
er
-
so
lu
bl
e 
vi
ta
m
in
 st
at
us
 a
fte
r a
dju
sti
ng
 fo
r s
oc
iod
em
og
rap
hic
 an
d l
ife
sty
le 
va
ria
bl
es
 th
ro
ug
h 
ch
un
k-
w
ise
 m
od
el
in
g 
us
in
g 
da
ta
 fo
r a
du
lts
 ≥
20
 y,
 
N
H
A
N
ES
 2
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